Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: Clinical implications

D. J. Kwiatkowski, D. H. Harpole, J. Godlewski, J. E. Herndon, Dar-Bin Shieh, W. Richards, R. Blanco, H. J. Xu, G. M. Strauss, D. J. Sugarbaker

Research output: Contribution to journalArticle

Original languageEnglish
Number of pages1
JournalPneumologie
Volume53
Issue number2
Publication statusPublished - 1999 Dec 1

All Science Journal Classification (ASJC) codes

  • Pulmonary and Respiratory Medicine

Cite this

Kwiatkowski, D. J., Harpole, D. H., Godlewski, J., Herndon, J. E., Shieh, D-B., Richards, W., Blanco, R., Xu, H. J., Strauss, G. M., & Sugarbaker, D. J. (1999). Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: Clinical implications. Pneumologie, 53(2).